|
Net income
|
|
$11.7m
|
$21.3m
|
$24.4m
|
$29.5m
|
$27.9m
|
$41.6m
|
|
Depreciation
|
|
$1.3m
|
$1.4m
|
$1.4m
|
$1.7m
|
$1.7m
|
$1.5m
|
|
Amortization of intangibles
|
|
$286k
|
$285k
|
$286k
|
$285k
|
$286k
|
$286k
|
|
Amortization of subordinated notes issuance costs
|
|
—
|
$69k
|
$71k
|
$73k
|
$71k
|
$76k
|
|
Net amortization of investment premiums
|
|
$2.3m
|
$2.0m
|
$1.7m
|
$1.2m
|
$1.1m
|
$889k
|
|
Deferred income tax provision (benefit)
|
|
($260k)
|
($403k)
|
($958k)
|
$103k
|
$69k
|
$240k
|
|
Provision for credit losses
|
|
—
|
—
|
$9.5m
|
$7.9m
|
$7.7m
|
$7.7m
|
|
Accretion on loans
|
|
($2.8m)
|
($5.6m)
|
($3.6m)
|
($3.0m)
|
($2.2m)
|
($2.6m)
|
|
Charges on redemption of subordinated notes
|
|
—
|
—
|
—
|
—
|
—
|
$500k
|
|
Investment securities losses
|
|
($804k)
|
—
|
—
|
($107k)
|
—
|
$568k
|
|
Restricted stock expense
|
|
$413k
|
$475k
|
$166k
|
$53k
|
$5k
|
$0
|
|
Stock-based compensation
|
|
$154k
|
$69k
|
$503k
|
$818k
|
$1.8m
|
$1.1m
|
|
Earnings on bank owned life insurance
|
|
($702k)
|
($793k)
|
($950k)
|
($984k)
|
($815k)
|
($878k)
|
|
Gain on bank owned life insurance proceeds
|
|
—
|
—
|
—
|
—
|
—
|
($3.6m)
|
|
Gain on sale of asset
|
|
—
|
—
|
—
|
—
|
—
|
($1.2m)
|
|
Accrued interest receivable
|
|
($3.1m)
|
($349k)
|
$323k
|
$386k
|
($746k)
|
($3.7m)
|
|
Other assets
|
|
($4.0m)
|
($5.6m)
|
($3.2m)
|
$3.2m
|
($2.7m)
|
($1.4m)
|
|
Other liabilities
|
|
$1.5m
|
$5.1m
|
$863k
|
$3.5m
|
$611k
|
$2.6m
|
|
Proceeds from redemptions of restricted investment in bank stocks
|
|
—
|
$15k
|
$4.8m
|
$49.0m
|
$60.3m
|
$53.8m
|
|
Net decrease (increase) in loans
|
|
($216.0m)
|
($125.8m)
|
($279.7m)
|
($179.1m)
|
($73.3m)
|
($137.5m)
|
|
Purchases of premises and equipment
|
|
($692k)
|
($2.0m)
|
($1.5m)
|
($3.5m)
|
($1.7m)
|
($2.5m)
|
|
Disposal of premises and equipment
|
|
—
|
—
|
—
|
$435k
|
$46k
|
—
|
|
Proceeds from sale of premises and equipment
|
|
—
|
—
|
—
|
$435k
|
$375k
|
$2.5m
|
|
Proceeds from bank owned life insurance
|
|
—
|
—
|
—
|
—
|
—
|
$13.5m
|
|
Net increase in deposits
|
|
$406.2m
|
$425.1m
|
$60.0m
|
$64.4m
|
$114.6m
|
$157.0m
|
|
Net change in FHLB advances, short term
|
|
—
|
—
|
$131.5m
|
$93.0m
|
($111.0m)
|
($113.5m)
|
|
Redemption of subordinated notes
|
|
—
|
—
|
—
|
—
|
—
|
($20.0m)
|
|
Issuance of subordinated notes, net of issuance costs
|
|
$19.3m
|
—
|
—
|
—
|
—
|
$24.6m
|
|
Capital raise, net of issuance costs
|
|
—
|
$35.3m
|
—
|
—
|
—
|
$43.4m
|
|
Purchases of treasury stock
|
|
($1.2m)
|
($379k)
|
($308k)
|
($447k)
|
($518k)
|
($158k)
|
|
Lease liabilities arising from obtaining right-of-use assets
|
|
$1.9m
|
$3.0m
|
$1.4m
|
$1.1m
|
$513k
|
$1.8m
|
|
Net cash from operating activities
|
|
$11.3m
|
$20.3m
|
$30.5m
|
$44.5m
|
$34.6m
|
$43.8m
|
|
Purchases of investment securities available-for-sale
|
|
($218.8m)
|
($258.2m)
|
($211.7m)
|
($6.8m)
|
($5.4m)
|
($22.6m)
|
|
Purchase of restricted investment in bank stocks
|
|
$25k
|
($783k)
|
($12.1m)
|
($54.0m)
|
($55.5m)
|
($50.0m)
|
|
Proceeds from sale of investment securities available-for-sale
|
|
—
|
—
|
—
|
$7.3m
|
—
|
$13.7m
|
|
Proceeds from paydowns of investment securities available-for-sale
|
|
$100.9m
|
$84.3m
|
$57.6m
|
$37.7m
|
$35.6m
|
$38.4m
|
|
Proceeds from maturities and calls of investment securities available-for-sale
|
|
$46.9m
|
$29.6m
|
$8.6m
|
$4.1m
|
$10.2m
|
$16.6m
|
|
Net cash from/(used) by investing activities
|
|
($331.0m)
|
($291.3m)
|
($434.1m)
|
($144.9m)
|
($29.4m)
|
($74.2m)
|
|
Cash dividends paid
|
|
($3.6m)
|
($4.0m)
|
($4.7m)
|
($5.2m)
|
($5.3m)
|
($7.1m)
|
|
Net cash from/(used) financing activities
|
|
$415.7m
|
$455.9m
|
$183.5m
|
$161.7m
|
($2.2m)
|
$84.2m
|
|
Net change in cash and cash equivalents
|
|
$96.1m
|
$184.9m
|
($220.1m)
|
$61.3m
|
$3.0m
|
$53.9m
|
|
Beginning cash and cash equivalents
|
|
$121.2m
|
$306.2m
|
$86.1m
|
$147.4m
|
$150.3m
|
$204.2m
|
|
Interest paid
|
|
$4.6m
|
$4.0m
|
$6.1m
|
$27.5m
|
$36.9m
|
$30.5m
|
|
Income taxes paid
|
|
$3.0m
|
$3.7m
|
$7.3m
|
$7.8m
|
$10.1m
|
$10.4m
|